Hitomi Yuki

13PUBLICATIONS
49CO-AUTHORS
Molecular targetsPharmaceutical delivery technologiesBiomolecular modelling and designMedical infection agents (incl. prions)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 27, 2026
Small-molecule RAS/RAF inhibitors target RAS-driven cancers via allosteric RAF disruption.

|Feb 27, 2026
Data-Driven Design of PROTAC Linkers to Improve PROTAC Cell Membrane Permeability.

Yuki Murakami, Shoichi Ishida, Nobuo Cho

|Apr 06, 2023
Quantum Chemical Interaction Analysis between SARS-CoV-2 Main Protease and Ensitrelvir Compared with Its Initial Screening Hit.

Chiduru Watanabe, Shigenori Tanaka, Yoshio Okiyama

|Dec 09, 2022
Identifying antibiotics based on structural differences in the conserved allostery from mitochondrial heme-copper oxidases.

Yuya Nishida, Sachiko Yanagisawa, Rikuri Morita

|Feb 05, 2022
Combined inhibition of XIAP and BCL2 drives maximal therapeutic efficacy in genetically diverse aggressive acute myeloid leukemia.

Mari Hashimoto, Yoriko Saito, Ryo Nakagawa

|Feb 04, 2021
The ubiquinone synthesis pathway is a promising drug target for Chagas disease.

Takeshi Nara, Yukari Nakagawa, Keiko Tsuganezawa

Pageof 3

Frequent Collaborators

7 joint publications

Teruki Honma

3 joint publications

Chiduru Watanabe

3 joint publications

Takashi Kumasaka

3 joint publications

Shigenori Tanaka